Danieli MG - Search Results

1

Danieli MG, Antonelli E, Piga MA, Claudi I, Palmeri D, Tonacci A, Allegra A, Gangemi S. Danieli MG, et al. Autoimmun Rev. 2022 Sep;21(9):103142. doi: 10.1016/j.autrev.2022.103142. Epub 2022 Jul 16. Autoimmun Rev. 2022. PMID: 35853572 Review.

2

A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases.

Danieli MG, Tonacci A, Paladini A, Longhi E, Moroncini G, Allegra A, Sansone F, Gangemi S. Danieli MG, et al. Autoimmun Rev. 2022 Jun;21(6):103105. doi: 10.1016/j.autrev.2022.103105. Epub 2022 Apr 19. Autoimmun Rev. 2022. PMID: 35452850 Review.

3

Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease.

Danieli MG, Piga MA, Paladini A, Longhi E, Mezzanotte C, Moroncini G, Shoenfeld Y. Danieli MG, et al. Scand J Immunol. 2021 Nov;94(5):e13101. doi: 10.1111/sji.13101. Epub 2021 Sep 16. Scand J Immunol. 2021. PMID: 34940980 Free PMC article. Review.

4

Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review.

Danieli MG, Gelardi C, Pedini V, Moretti R, Gabrielli A, Logullo F. Danieli MG, et al. Autoimmun Rev. 2014 Dec;13(12):1182-8. doi: 10.1016/j.autrev.2014.08.018. Epub 2014 Aug 27. Autoimmun Rev. 2014. PMID: 25172241 Review.

5

Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma).

Danieli MG, Candela M, Ricciatti AM, Reginelli R, Danieli G, Cohen IR, Gabrielli A. Danieli MG, et al. Among authors: danieli g. J Autoimmun. 1992 Aug;5(4):443-52. doi: 10.1016/0896-8411(92)90004-a. J Autoimmun. 1992. PMID: 1418288

6

Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems.

Danieli MG, Gelardi C, Pedini V, Menghini D, Benfaremo D, Gabrielli A. Danieli MG, et al. Autoimmun Rev. 2020 Jan;19(1):102426. doi: 10.1016/j.autrev.2019.102426. Epub 2019 Nov 14. Autoimmun Rev. 2020. PMID: 31734407

7

Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application.

Danieli MG, Pettinari L, Moretti R, Logullo F, Gabrielli A. Danieli MG, et al. Autoimmun Rev. 2011 Jan;10(3):144-9. doi: 10.1016/j.autrev.2010.09.004. Epub 2010 Sep 19. Autoimmun Rev. 2011. PMID: 20858553

8

Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.

Danieli MG, Gambini S, Pettinari L, Logullo F, Veronesi G, Gabrielli A. Danieli MG, et al. Autoimmun Rev. 2014 Oct;13(10):1048-54. doi: 10.1016/j.autrev.2014.08.023. Epub 2014 Aug 23. Autoimmun Rev. 2014. PMID: 25183232

9

[Intravenous immunoglobulin treatment in autoimmune diseases].

Danieli MG, Calcabrini L, Marchetti A, Calabrese V, Pettinari L, Massaccesi C, Gabrielli A, Danieli G. Danieli MG, et al. Among authors: danieli g. Recenti Prog Med. 2007 Jun;98(6):322-6. Recenti Prog Med. 2007. PMID: 17580523 Italian.

10

Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.

Danieli MG, Calcabrini L, Calabrese V, Marchetti A, Logullo F, Gabrielli A. Danieli MG, et al. Autoimmun Rev. 2009 Dec;9(2):124-7. doi: 10.1016/j.autrev.2009.04.003. Epub 2009 Apr 19. Autoimmun Rev. 2009. PMID: 19386287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page